Shanxi Dayu Biological Functions Co (BJSE:920970) Beneish M-Score: -1.43 (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920970 Shanxi Dayu Biological Functions Co Ltd BJSE:920970
66 GF Score
Price ¥6.58
GF Value ¥7.30
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Shanxi Dayu Biological Functions Co Beneish M-Score?

Shanxi Dayu Biological Functions Co BJSE:920970 66 Beneish M-Score is -1.43 as of Sep. 02, 2026. GuruFocus rates BJSE:920970 with a GF Score™ of 66/100 and a GF Value™ of ¥7.30 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 832 Biotechnology companies, Shanxi Dayu Biological Functions Co ranks worse than 71.03% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.43 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Shanxi Dayu Biological Functions Co's Beneish M-Score or its related term are showing as below:

BJSE:920970' s Beneish M-Score Range Over the Past 10 Years
Min: -3.36   Med: -1.96   Max: 16.01
Current: -1.43

During the past 11 years, the highest Beneish M-Score of Shanxi Dayu Biological Functions Co was 16.01. The lowest was -3.36. And the median was -1.96.


Shanxi Dayu Biological Functions Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shanxi Dayu Biological Functions Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanxi Dayu Biological Functions Co Beneish M-Score Chart

Shanxi Dayu Biological Functions Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.90 -1.46 -3.15 -2.02

Shanxi Dayu Biological Functions Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.99 -2.56 -2.02 -1.59 -1.43

BJSE:920970 vs VRTX, REGN, MRNA: Beneish M-Score Comparison

For the Biotechnology subindustry, Shanxi Dayu Biological Functions Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanxi Dayu Biological Functions Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanxi Dayu Biological Functions Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shanxi Dayu Biological Functions Co's Beneish M-Score falls into.


BJSE:920970
66GF Score
Shanxi Dayu Biological Functions Co Ltd BJSE:920970
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanxi Dayu Biological Functions Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shanxi Dayu Biological Functions Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.549+0.528 * 3.7862+0.404 * 1.2094+0.892 * 1.3906+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7026+4.679 * -0.067332-0.327 * 1.5273
=-1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was ¥17.3 Mil.
Revenue was 38.174 + 33.74 + 75.027 + 30.272 = ¥177.2 Mil.
Gross Profit was 4.59 + 4.588 + -5.394 + 6.85 = ¥10.6 Mil.
Total Current Assets was ¥103.7 Mil.
Total Assets was ¥462.1 Mil.
Property, Plant and Equipment(Net PPE) was ¥303.7 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥8.6 Mil.
Total Current Liabilities was ¥159.7 Mil.
Long-Term Debt & Capital Lease Obligation was ¥29.9 Mil.
Net Income was -9.133 + -17.417 + -19.137 + -1.693 = ¥-47.4 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -4.199 + -18.618 + 23.854 + -17.303 = ¥-16.3 Mil.
Total Receivables was ¥22.7 Mil.
Revenue was 32.708 + 29.473 + 33.267 + 31.992 = ¥127.4 Mil.
Gross Profit was 6.077 + 5.897 + 8.794 + 8.186 = ¥29.0 Mil.
Total Current Assets was ¥107.8 Mil.
Total Assets was ¥436.0 Mil.
Property, Plant and Equipment(Net PPE) was ¥285.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥8.8 Mil.
Total Current Liabilities was ¥96.3 Mil.
Long-Term Debt & Capital Lease Obligation was ¥20.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(17.325 / 177.213) / (22.693 / 127.44)
=0.097764 / 0.178068
=0.549

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(28.954 / 127.44) / (10.634 / 177.213)
=0.227197 / 0.060007
=3.7862

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (103.673 + 303.733) / 462.098) / (1 - (107.833 + 285.504) / 436.006)
=0.118356 / 0.097863
=1.2094

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=177.213 / 127.44
=1.3906

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 285.504)) / (0 / (0 + 303.733))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.601 / 177.213) / (8.803 / 127.44)
=0.048535 / 0.069076
=0.7026

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((29.85 + 159.703) / 462.098) / ((20.782 + 96.322) / 436.006)
=0.410201 / 0.268583
=1.5273

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-47.38 - 0 - -16.266) / 462.098
=-0.067332

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shanxi Dayu Biological Functions Co has a M-score of -1.43 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.43 mean?
Shanxi Dayu Biological Functions Co (BJSE:920970) has a Beneish M-Score of -1.43 as of Sep. 02, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanxi Dayu Biological Functions Co and its competitors. According to the industry distribution chart, Shanxi Dayu Biological Functions Co ranks #591 out of 832 companies in the Biotechnology industry, placing it in the top 71%.
Is Shanxi Dayu Biological Functions Co's Beneish M-Score too high?
Shanxi Dayu Biological Functions Co's current Beneish M-Score is -1.43. Based on the distribution chart, Shanxi Dayu Biological Functions Co ranks #591 out of 832 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanxi Dayu Biological Functions Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanxi Dayu Biological Functions Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanxi Dayu Biological Functions Co ranks #591 out of 832 companies for Beneish M-Score. This places Shanxi Dayu Biological Functions Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanxi Dayu Biological Functions Co and its competitors. Shanxi Dayu Biological Functions Co's current Beneish M-Score is -1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanxi Dayu Biological Functions Co stock overvalued right now?
Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co (BJSE:920970) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.30, compared to a current price of ¥6.58 — trading 9.9% below its estimated fair value. The current Beneish M-Score is -1.43. Shanxi Dayu Biological Functions Co's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shanxi Dayu Biological Functions Co (BJSE:920970), the current Beneish M-Score is -1.43 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanxi Dayu Biological Functions Co (BJSE:920970) Overvalued in 2026?

Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co stock appears to be undervalued. The current stock price of ¥6.58 is trading 9.9% below its estimated GF Value™ of ¥7.30. GuruFocus considers Shanxi Dayu Biological Functions Co to be Modestly Undervalued.

Key valuation signals for BJSE:920970:

  • Beneish M-Score: -1.43
  • GF Value™: ¥7.30 vs. price of ¥6.58 (9.9% below fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the BJSE:920970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanxi Dayu Biological Functions Co Business Description

Address West side of Yongle South Road Development Zone, Ruicheng County, Shanxi Province, South of Lido Hotel, Yuncheng City, CHN, 044600
Shanxi Dayu Biological Functions Co Ltd engages in the research and development of bioengineering technology and product application. Its main products are probiotics, enzyme preparations, fermented traditional Chinese medicine, biological preparations, and veterinary preparations.
66GF Score

Get the complete analysis for BJSE:920970

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.58
Price
¥7.30
GF Value